Find your next M&A target
Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.
Project details
Korean AI medical diagnosis firm seeks USD 2.5 million investment
| Project region | Korea |
|---|---|
| Industry | Healthcare |
| Total value of the target | N/A |
| Expected target net rate of return after deducting all taxes and fees | N/A |
| Validity period of pending order | 365 |
CONTACT ADVISOR
Simon Laube
Assistant Manager, International Business Advisory
| Project highlights | AI diagnosis - national system |
|---|---|
| Project description |
The Korean AI medical company's products include a cervical cancer diagnosis AI system, an early AI diagnosis for stroke risk, a stroke risk prediction AI system based ob carotid ultrasound images, and a cerebral aneurysm rupture risk prediction AI system based on cerebral angiography images. The company has developed a international system with various languages to ensure that all medical personnel around the world can use its AI diagnosis solutions. Its partners include Swedish medical device manufacturer Gynius plus AB and Canadian health care company Variational AI. The company seeks USD 2.5 million for equity financing. |
Enquire for more information about our services, and how we can help solve challenges for your organization
Contact UsOur Clients
Discover our esteemed global clients across diverse sectors. We believe in providing our clients with exceptional service and a commitment to being their partner for growth in Asia.
See what our clients say about us
